한글목차

보고서 개요

세계의 핵산 분리·정제 시장 규모는 2023년 64억 달러에서 예측 기간중 8.1%의 CAGR로 추이하며, 2028년에는 94억 달러 규모로 성장할 것으로 예측됩니다.

자동화의 발전, R&D 활동의 활성화, 기술 발전 증가가 이 시장의 성장 요인으로 꼽히고 있습니다.

제품별로는 키트 부문이 2022년 가장 큰 비중을 차지할 것으로 예상됩니다. 이 부문의 주요 성장 요인으로는 분자진단, 유전자 시퀀싱, 유전자 클로닝 등의 분야에서 키트의 사용 편의성, 저렴한 비용, 주요 기업의 첨단 키트 개발 및 출시에 대한 지속적인 노력 등이 꼽힙니다.

유형별로는 플라스미드 DNA 분리 및 정제 부문이 2022년 가장 큰 점유율을 차지할 것으로 예상됩니다. 이 부문은 플라스미드 DNA를 위해 특별히 설계된 다양한 추출 및 처리 키트를 광범위하게 사용할 수 있는 것이 장점입니다. 또한 유전자 발현 프로파일링에서 플라스미드 DNA의 사용이 증가하고 다양한 다운스트림 공정에 광범위하게 적용되고 있는 것도 이 부문의 성장에 기여하고 있습니다.

용도별로는 진단 부문이 2022년 가장 큰 점유율을 차지할 것으로 예상됩니다. 병원체 식별을 위한 일상적인 샘플 처리에서 DNA 및 RNA 분리의 사용 확대, 환자들의 유전체 진단에 대한 인식 증가, 질병 진단에서 유전체 시퀀싱의 효율성 향상 등 몇 가지 요인이 이 부문의 우위에 기여하고 있습니다.

세계의 핵산 분리·정제 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회 분석, 기술·특허 동향, 사례 연구, 법규제 환경, 시장 규모의 추이·예측, 각종 구분·지역별 상세 분석, 경쟁 구도, 주요 기업의 개요 등을 정리하여 전해드립니다.

목차

제1장 서론

제2장 조사 방법

제3장 주요 요약

제4장 중요 인사이트

제5장 시장 개요

• 시장 역학
  • 촉진요인
  • 억제요인
  • 기회
  • 과제
• 고객의 사업에 영향을 미치는 동향/디스럽션
• 특허 분석
• 밸류체인 분석
• 공급망 분석
• 에코시스템 분석
• 주요 컨퍼런스와 이벤트
• 가격 분석
• 기술 분석
• Porter의 산업 분석
• 규제 분석
• 주요 이해관계자와 구입 기준

제6장 핵산 분리·정제 시장 : 제품별

• 키트
• 시약
• 기기
  • 자동 계기
  • 수동 계기

제7장 핵산 분리·정제 시장 : 방법별

• 자기 비즈 기반 분리·정제
• 시약 기반 분리·정제
• 칼럼 기반 분리·정제
• 기타

제8장 핵산 분리·정제 시장 : 유형별

• 플라스미드 DNA 분리·정제
• 토탈 RNA 분리·정제
• 게놈 DNA 분리·정제
• 메신저 RNA 분리·정제
• 순환 핵산 분리·정제
• 미크로 RNA 분리·정제
• 기타

제9장 핵산 분리·정제 시장 : 용도별

• 진단
• Drug Discovery·개발
• 맞춤형 의료
• 농업·동물 연구
• 기타

제10장 핵산 분리·정제 시장 : 최종사용자별

• 병원·진단 센터
• 학술·정부 연구기관
• 제약·바이오테크놀러지 회사
• CRO
• 기타

제11장 핵산 분리·정제 시장 : 지역별

• 북미
• 유럽
• 아시아태평양
• 라틴아메리카
• 중동 및 아프리카

제12장 경쟁 구도

• 주요 기업의 채택 전략
• 매출 분석
• 시장 점유율 분석
• 기업 평가 매트릭스
• 신규 기업/중소기업 평가 매트릭스
• 경쟁 시나리오와 동향

제13장 기업 개요

• 주요 기업
  • THERMO FISHER SCIENTIFIC INC.
  • QIAGEN
  • F. HOFFMANN-LA ROCHE LTD.
  • MERCK KGAA
  • PROMEGA CORPORATION
  • AGILENT TECHNOLOGIES, INC.
  • DANAHER
  • BIO-RAD LABORATORIES, INC.
  • ILLUMINA, INC.
  • TAKARA BIO INC.
  • NEW ENGLAND BIOLABS
  • ABCAM PLC
• 기타 기업
  • KILPEST INDIA LIMITED
  • APICAL SCIENTIFIC SDN. BHD.
  • ENDRESS+HAUSER GROUP SERVICES AG
  • GENAXXON BIOSCIENCE GMBH
  • LGC BIOSEARCH TECHNOLOGIES
  • ZYMO RESEARCH CORPORATION
  • NORGEN BIOTEK CORP.
  • OMEGA BIO-TEK, INC.
  • FAVORGEN BIOTECH CORPORATION
  • TIANGEN BIOTECH(BEIJING) CO., LTD.
  • AUTOGEN INC.
  • PCR BIOSYSTEMS
  • BIOGENUIX

제14장 부록

영문목차

Report Description

The global Nucleic acid isolation and purification market is projected to reach USD 9.4 billion by 2028 from USD 6.4 billion in 2023, at a CAGR of 8.1% during the forecast period. The factors responsible for the growth of this market include increasing automation, growing research and development activities and increasing technological advancements.

In 2022, the kits segment accounted for the largest share of the global nucleic acid isolation and purification market.

Based on products, the nucleic acid isolation and purification market has been segmented into kits, reagents, and instruments. The instruments segment is further segmented into automatic and manual instruments. In 2022, the kits segment accounted for the largest share of the global nucleic acid isolation and purification market. Factors responsible for the growth in this market include easy usage and cost of kits in applications including molecular diagnostics, gene sequencing, and gene cloning, and the continuous focus of key market players on developing and launching advanced kits.

In 2022, the plasmid DNA isolation segment accounted for the largest share of the market.

Based on type, the global nucleic acid isolation and purification market is segmented into plasmid DNA, total RNA, circulating nucleic acid, genomic DNA, messenger RNA, microRNA, and other nucleic acid isolation and purification types. In 2022, the plasmid DNA isolation and purification segment dominated the global nucleic acid isolation and purification market. The growth of this segment can be attributed to several factors. Firstly, the market benefits from the wide availability of diverse extraction and processing kits specifically designed for plasmid DNA. Additionally, the increasing utilization of plasmid DNA in gene expression profiling and its widespread application in various downstream processes contribute to the segment's expansion.

In 2022, the diagnostics segment accounted for the largest share of the global nucleic acid isolation and purification market.

Based on application, the global nucleic acid isolation and purification market is segmented into personalized medicine, diagnostics, agriculture & animal research, drug discovery & development, and other applications. The diagnostics segment dominated the global nucleic acid isolation and purification market in 2022. Several factors contributed to the segment's prominence including the growing utilization of DNA and RNA isolation in routine sample processing for pathogen identification, the increasing awareness of genomic diagnostics among patients and the improved efficiency of genomics sequencing in disease diagnosis.

In 2022, North America accounted for the largest share of the nucleic acid isolation and purification market.

Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. In 2022, North America dominated the global nucleic acid isolation and purification market. The dominance of the regon can be attributed to factors such as presence of key players in the region, increasing R&D spending in pharmaceutical and biotechnology companies, government support, and technological advancements, in the region.

The primary interviews conducted for this report can be categorized as follows:

• By Respondent: Supply Side- 80% and Demand Side 20%
• By Designation: Managers- 45%, CXOs and Directors - 30%, and Executives - 25%
• By Region: North America -37%, Europe -30%, Asia-Pacific -25%, Latin America -5%, Middle East & Africa- 3%

List of Companies Profiled in the Report:

• Thermo Fisher Scientific Inc. (US)
• Merck KGaA (Germany)
• QIAGEN (Germany)
• F. Hoffmann-La Roche Ltd. (Switzerland)
• Promega Corporation (US)
• Agilent Technologies, Inc. (US)
• Danaher(US)
• Bio-Rad Laboratories, Inc. (US)
• Illumina, Inc. (US)
• Takara Bio Inc. (Japan)
• New England Biolabs (US)
• Abcam Plc (UK)
• KILPEST India Limited (India)
• Apical Scientific Sdn. Bhd. (Malaysia)
• Endress+Hauser Group Services AG (Switzerland)
• GENAXXON bioscience GmbH (Germany)
• LGC Biosearch Technologies (US)
• Zymo Research Corporation (US)
• Norgen Biotek Corp. (Canada)
• Omega Bio-Tek, Inc. (US)
• FAVORGEN Biotech Corp. (China)
• TIANGEN Biotech (Beijing) Co., Ltd. (China)
• AutoGen Inc. (US)
• PCR Biosystems (UK)
• Biogenuix (India)

Research Coverage: The report comprehensively encompasses in-depth information about the significant factors that impact the growth of the NAIP market, including drivers, restraints, challenges, and opportunities. A meticulous analysis of the leading industry players has been conducted to offer insights into their business overview, solutions, and products. Additionally, the report examines their key strategies, such as partnerships, agreements, new product launches, mergers and acquisitions, and recent developments associated with the NAIP market. Furthermore, the report covers a competitive analysis of emerging startups in the NAIP market ecosystem.

Reasons to Buy the Report

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall NAIP market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

• Analysis of key drivers (Increasing R&D activities, Technological advancements and increasing automation, Growing demand for molecular diagnostics), restraints (High cost of automated instruments), opportunities (Growth opportunities in emerging economies, Improving regulatory and reimbursement scenario, Molecular diagnostics and personalized medicine), and challenges (Operational barriers and shortage of skilled professionals, and Introduction of alternative technologies) influencing the growth of the nucleic acid isolation and purification market.
• Product Development/Innovation: Detailed insights on upcoming trends, research & development activities, and new product launches in the nucleic acid isolation and purification market.
• Market Development: Comprehensive information about lucrative markets - the report analyses the nucleic acid isolation and purification market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the Nucleic acid isolation and purification market
• Competitive Assessment: In-depth assessment of market shares, growth strategies and product offerings of leading players like Thermo Fisher Scientific Inc. (US), QIAGEN (Germany), Merck KGaA (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), Promega Corporation (US), Agilent Technologies, Inc. (US), Danaher(US), Bio-Rad Laboratories, Inc. (US), Illumina, Inc. (US), Takara Bio Inc. (Japan), New England Biolabs (US), Abcam Plc (UK), KILPEST India Limited (India), Apical Scientific Sdn. Bhd. (Malaysia), Endress+Hauser Group Services AG (Switzerland), GENAXXON bioscience GmbH (Germany), LGC Biosearch Technologies (US), Zymo Research Corporation (US), Norgen Biotek Corp. (Canada), Omega Bio-Tek, Inc. (US), FAVORGEN Biotech Corp. (China), TIANGEN Biotech (Beijing) Co., Ltd. (China), AutoGen Inc. (US), PCR Biosystems (UK), and Biogenuix (India).

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
  • 1.2.1 INCLUSIONS & EXCLUSIONS
• 1.3 STUDY SCOPE
  • 1.3.1 MARKETS COVERED
  • 1.3.2 YEARS CONSIDERED
• 1.4 CURRENCY
• 1.5 LIMITATIONS
• 1.6 STAKEHOLDERS
• 1.7 SUMMARY OF CHANGES
• 1.8 RECESSION IMPACT

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • FIGURE 1 RESEARCH DESIGN
  • 2.1.1 SECONDARY DATA
  • 2.1.2 PRIMARY DATA
  • FIGURE 2 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: BREAKDOWN OF PRIMARIES
• 2.2 MARKET SIZE ESTIMATION
  • FIGURE 3 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: MARKET SIZE ESTIMATION FOR SUPPLY-SIDE ANALYSIS (2022)
  • FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (REVENUE SHARE ANALYSIS) FOR 2022
  • FIGURE 5 ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE ANALYSIS FOR 2022
  • 2.2.1 PRIMARY INSIGHTS
  • FIGURE 6 MARKET VALIDATION FROM PRIMARY EXPERTS
  • FIGURE 7 TOP-DOWN APPROACH
• 2.3 MARKET GROWTH RATE PROJECTIONS
  • FIGURE 8 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: CAGR PROJECTIONS FOR FORECAST PERIOD
  • FIGURE 9 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, CHALLENGES, AND OPPORTUNITIES
• 2.4 DATA TRIANGULATION APPROACH
  • FIGURE 10 DATA TRIANGULATION METHODOLOGY
• 2.5 STUDY ASSUMPTIONS
• 2.6 RISK ANALYSIS
• 2.7 RECESSION IMPACT ANALYSIS
  • TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021-2028 (% GROWTH)
  • TABLE 2 US HEALTH EXPENDITURE, 2019-2022 (USD MILLION)
  • TABLE 3 US HEALTH EXPENDITURE, 2023-2028 (USD MILLION)

3 EXECUTIVE SUMMARY

• FIGURE 11 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION)
• FIGURE 12 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2023 VS. 2028 (USD MILLION)
• FIGURE 13 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
• FIGURE 14 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION)
• FIGURE 15 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
• FIGURE 16 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: GEOGRAPHIC SNAPSHOT

4 PREMIUM INSIGHTS

• 4.1 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET OVERVIEW
  • FIGURE 17 TECHNOLOGICAL ADVANCEMENTS AND INCREASED AUTOMATION TO DRIVE MARKET GROWTH
• 4.2 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT AND COUNTRY
  • FIGURE 18 KITS DOMINATED NORTH AMERICAN NUCLEIC ACID ISOLATION AND PURIFICATION PRODUCTS MARKET IN 2023
• 4.3 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET SHARE, BY TYPE, 2022
  • FIGURE 19 PLASMID DNA ISOLATION AND PURIFICATION SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2022
• 4.4 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET SHARE, BY PRODUCT, 2022
  • FIGURE 20 KITS SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2022
• 4.5 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET SHARE, BY METHOD, 2022
  • FIGURE 21 MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION SEGMENT ACCOUNTED FOR THE LARGEST MARKET SHARE IN 2022
• 4.6 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET SHARE, BY APPLICATION, 2022
  • FIGURE 22 DIAGNOSTICS SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2022
• 4.7 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET SHARE, BY END USER, 2022
  • FIGURE 23 HOSPITALS & DIAGNOSTIC CENTERS SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2022
• 4.8 GEOGRAPHICAL SNAPSHOT OF NUCLEIC ACID ISOLATION AND PURIFICATION MARKET
  • FIGURE 24 CHINA TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • FIGURE 25 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • TABLE 4 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • 5.2.1 DRIVERS
    • 5.2.1.1 Increasing R&D activities
    • 5.2.1.2 Technological advancements and increasing automation
    • 5.2.1.3 Growing demand for molecular diagnostics
  • TABLE 5 ESTIMATED NUMBER OF NEW CANCER CASES GLOBALLY, BY TYPE OF CANCER, 2020 VS. 2025
  • TABLE 6 GLOBAL CANCER INCIDENCE, BY REGION, 2020 VS. 2025
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 High cost of automated instruments
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Growth opportunities in emerging economies
    • 5.2.3.2 Improving regulatory and reimbursement scenario
    • 5.2.3.3 Molecular diagnostics and personalized medicine
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Operational barriers and shortage of skilled professionals
    • 5.2.4.2 Introduction of alternative technologies
• 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • FIGURE 26 REVENUE SHIFT & NEW REVENUE POCKETS FOR NUCLEIC ACID ISOLATION AND PURIFICATION MARKET PROVIDERS
• 5.4 PATENT ANALYSIS
  • FIGURE 27 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: PATENT APPLICATIONS, OCTOBER 2013-OCTOBER 2023
  • TABLE 7 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: INDICATIVE LIST OF PATENTS
• 5.5 VALUE CHAIN ANALYSIS
  • FIGURE 28 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: VALUE CHAIN ANALYSIS
• 5.6 SUPPLY CHAIN ANALYSIS
  • FIGURE 29 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: SUPPLY CHAIN ANALYSIS
• 5.7 ECOSYSTEM ANALYSIS
  • TABLE 8 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: ECOSYSTEM ANALYSIS
• 5.8 KEY CONFERENCES & EVENTS IN 2023-2024
  • TABLE 9 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: DETAILED LIST OF CONFERENCES & EVENTS IN 2023-2024
• 5.9 PRICING ANALYSIS
  • 5.9.1 AVERAGE SELLING PRICE, BY PRODUCT
  • TABLE 10 AVERAGE SELLING PRICE OF NUCLEIC ACID ISOLATION AND PURIFICATION PRODUCTS, 2022-2023 (USD)
  • 5.9.2 AVERAGE SELLING PRICE, BY REGION
  • TABLE 11 AVERAGE SELLING PRICE OF NUCLEIC ACID ISOLATION AND PURIFICATION PRODUCTS, BY REGION, 2022-2023 (USD)
• 5.10 TECHNOLOGY ANALYSIS
• 5.11 PORTER'S FIVE FORCES ANALYSIS
  • TABLE 12 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: PORTER'S FIVE FORCES ANALYSIS
  • 5.11.1 THREAT OF NEW ENTRANTS
  • 5.11.2 THREAT OF SUBSTITUTES
  • 5.11.3 BARGAINING POWER OF SUPPLIERS
  • 5.11.4 BARGAINING POWER OF BUYERS
  • 5.11.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.12 REGULATORY ANALYSIS
  • 5.12.1 REGULATORY BODIES
  • TABLE 13 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 14 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 15 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 16 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 17 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• 5.13 KEY STAKEHOLDERS & BUYING CRITERIA
  • 5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • FIGURE 30 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF NUCLEIC ACID ISOLATION AND PURIFICATION PRODUCTS
  • 5.13.2 BUYING CRITERIA FOR NUCLEIC ACID ISOLATION AND PURIFICATION PRODUCTS
  • FIGURE 31 KEY BUYING CRITERIA FOR END USERS

6 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT

• 6.1 INTRODUCTION
  • TABLE 18 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
• 6.2 KITS
  • 6.2.1 KITS TO ACCOUNT FOR LARGEST SHARE OF MARKET DURING FORECAST PERIOD
  • TABLE 19 NUCLEIC ACID ISOLATION AND PURIFICATION KITS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 20 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION KITS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 21 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION KITS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 22 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION KITS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 23 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION KITS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 24 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION KITS MARKET, BY REGION, 2021-2028 (USD MILLION)
• 6.3 REAGENTS
  • 6.3.1 AVAILABILITY OF READY-TO-USE REAGENTS TO DRIVE GROWTH
  • TABLE 25 NUCLEIC ACID ISOLATION AND PURIFICATION REAGENTS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 26 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION REAGENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 27 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION REAGENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 28 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION REAGENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 29 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION REAGENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 30 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION REAGENTS MARKET, BY REGION, 2021-2028 (USD MILLION)
• 6.4 INSTRUMENTS
  • TABLE 31 NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 32 NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 33 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 34 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 35 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 36 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 37 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 6.4.1 AUTOMATIC INSTRUMENTS
    • 6.4.1.1 Benefits of automatic instruments to drive growth
  • TABLE 38 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR AUTOMATIC INSTRUMENTS, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 39 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR AUTOMATIC INSTRUMENTS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 40 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR AUTOMATIC INSTRUMENTS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 41 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR AUTOMATIC INSTRUMENTS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 42 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR AUTOMATIC INSTRUMENTS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 43 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR AUTOMATIC INSTRUMENTS, BY REGION, 2021-2028 (USD MILLION)
  • 6.4.2 MANUAL INSTRUMENTS
    • 6.4.2.1 Growing demand for nucleic acid isolation and purification in research and clinical applications to drive growth
  • TABLE 44 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR MANUAL INSTRUMENTS, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 45 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR MANUAL INSTRUMENTS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 46 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR MANUAL INSTRUMENTS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 47 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR MANUAL INSTRUMENTS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 48 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR MANUAL INSTRUMENTS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 49 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR MANUAL INSTRUMENTS, BY REGION, 2021-2028 (USD MILLION)

7 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD

• 7.1 INTRODUCTION
  • TABLE 50 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2021-2028 (USD MILLION)
• 7.2 MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION
  • 7.2.1 MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION SEGMENT TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
  • TABLE 51 MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION MARKET, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 52 NORTH AMERICA: MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 53 EUROPE: MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 54 ASIA PACIFIC: MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 55 LATIN AMERICA: MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 56 MIDDLE EAST & AFRICA: MAGNETIC BEAD-BASED ISOLATION AND PURIFICATION MARKET, BY REGION, 2021-2028 (USD MILLION)
• 7.3 REAGENT-BASED ISOLATION AND PURIFICATION
  • 7.3.1 REAGENT-BASED ISOLATION AND PURIFICATION SEGMENT TO REGISTER STEADY GROWTH DURING FORECAST PERIOD
  • TABLE 57 REAGENT-BASED ISOLATION AND PURIFICATION MARKET, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 58 NORTH AMERICA: REAGENT-BASED ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 59 EUROPE: REAGENT-BASED ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 60 ASIA PACIFIC: REAGENT-BASED ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 61 LATIN AMERICA: REAGENT-BASED ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 62 MIDDLE EAST & AFRICA: REAGENT-BASED ISOLATION AND PURIFICATION MARKET, BY REGION, 2021-2028 (USD MILLION)
• 7.4 COLUMN-BASED ISOLATION AND PURIFICATION
  • 7.4.1 GROWING POPULARITY OF COLUMN-BASED ISOLATION AND PURIFICATION IN CURRENT KITS TO BOOST MARKET
  • TABLE 63 COLUMN-BASED ISOLATION AND PURIFICATION MARKET, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 64 NORTH AMERICA: COLUMN-BASED ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 65 EUROPE: COLUMN-BASED ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 66 ASIA PACIFIC: COLUMN-BASED ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 67 LATIN AMERICA: COLUMN-BASED ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 68 MIDDLE EAST & AFRICA: COLUMN-BASED ISOLATION AND PURIFICATION MARKET, BY REGION, 2021-2028 (USD MILLION)
• 7.5 OTHER ISOLATION AND PURIFICATION METHODS
  • TABLE 69 OTHER ISOLATION AND PURIFICATION METHODS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 70 NORTH AMERICA: OTHER ISOLATION AND PURIFICATION METHODS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 71 EUROPE: OTHER ISOLATION AND PURIFICATION METHODS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 72 ASIA PACIFIC: OTHER ISOLATION AND PURIFICATION METHODS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 73 LATIN AMERICA: OTHER ISOLATION AND PURIFICATION METHODS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 74 MIDDLE EAST & AFRICA: OTHER ISOLATION AND PURIFICATION METHODS MARKET, BY REGION, 2021-2028 (USD MILLION)

8 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE

• 8.1 INTRODUCTION
  • TABLE 75 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
• 8.2 PLASMID DNA ISOLATION AND PURIFICATION
  • 8.2.1 PLASMID DNA ISOLATION AND PURIFICATION TO ACCOUNT FOR LARGEST SHARE OF MARKET
  • TABLE 76 PLASMID DNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 77 NORTH AMERICA: PLASMID DNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 78 EUROPE: PLASMID DNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 79 ASIA PACIFIC: PLASMID DNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 80 LATIN AMERICA: PLASMID DNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 81 MIDDLE EAST & AFRICA: PLASMID DNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2021-2028 (USD MILLION)
• 8.3 TOTAL RNA ISOLATION AND PURIFICATION
  • 8.3.1 WIDE USE OF TOTAL RNA ISOLATION AND PURIFICATION FOR RESEARCH AND DIAGNOSTIC APPLICATIONS TO BOOST MARKET
  • TABLE 82 TOTAL RNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 83 NORTH AMERICA: TOTAL RNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 84 EUROPE: TOTAL RNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 85 ASIA PACIFIC: TOTAL RNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 86 LATIN AMERICA: TOTAL RNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 87 MIDDLE EAST & AFRICA: TOTAL RNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2021-2028 (USD MILLION)
• 8.4 GENOMIC DNA ISOLATION AND PURIFICATION
  • 8.4.1 IMPORTANCE OF GENOMIC DNA ISOLATION IN GENETIC-BASED TESTS TO SUPPORT GROWTH
  • TABLE 88 GENOMIC DNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 89 NORTH AMERICA: GENOMIC DNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 90 EUROPE: GENOMIC DNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 91 ASIA PACIFIC: GENOMIC DNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 92 LATIN AMERICA: GENOMIC DNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 93 MIDDLE EAST & AFRICA: GENOMIC DNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2021-2028 (USD MILLION)
• 8.5 MESSENGER RNA ISOLATION AND PURIFICATION
  • 8.5.1 ROLE PLAYED BY MESSENGER RNA ISOLATION AND PURIFICATION IN GENE EXPRESSION AND TRANSCRIPTOMICS TO DRIVE GROWTH
  • TABLE 94 MESSENGER RNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 95 NORTH AMERICA: MESSENGER RNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 96 EUROPE: MESSENGER RNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 97 ASIA PACIFIC: MESSENGER RNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 98 LATIN AMERICA: MESSENGER RNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 99 MIDDLE EAST & AFRICA: MESSENGER RNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2021-2028 (USD MILLION)
• 8.6 CIRCULATING NUCLEIC ACID ISOLATION AND PURIFICATION
  • 8.6.1 ABILITY OF CIRCULATING NAIP TO ENABLE COLLECTION OF GENETIC INFORMATION FROM BODY FLUIDS TO BOOST ADOPTION
  • TABLE 100 CIRCULATING NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 101 NORTH AMERICA: CIRCULATING NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 102 EUROPE: CIRCULATING NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 103 ASIA PACIFIC: CIRCULATING NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 104 LATIN AMERICA: CIRCULATING NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 105 MIDDLE EAST & AFRICA: CIRCULATING NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2021-2028 (USD MILLION)
• 8.7 MICRORNA ISOLATION AND PURIFICATION
  • 8.7.1 GROWING APPLICATIONS OF MICRORNA ISOLATION AND PURIFICATION IN DRUG DEVELOPMENT RESEARCH TO FUEL GROWTH
  • TABLE 106 MICRORNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 107 NORTH AMERICA: MICRORNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 108 EUROPE: MICRORNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 109 ASIA PACIFIC: MICRORNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 110 LATIN AMERICA: MICRORNA ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 111 MIDDLE EAST & AFRICA: MICRORNA ISOLATION AND PURIFICATION MARKET, BY REGION, 2021-2028 (USD MILLION)
• 8.8 OTHER NUCLEIC ACID ISOLATION AND PURIFICATION TYPES
  • TABLE 112 OTHER NUCLEIC ACID ISOLATION AND PURIFICATION TYPES MARKET, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 113 NORTH AMERICA: OTHER NUCLEIC ACID ISOLATION AND PURIFICATION TYPES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 114 EUROPE: OTHER NUCLEIC ACID ISOLATION AND PURIFICATION TYPES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 115 ASIA PACIFIC: OTHER NUCLEIC ACID ISOLATION AND PURIFICATION TYPES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 116 LATIN AMERICA: OTHER NUCLEIC ACID ISOLATION AND PURIFICATION TYPES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 117 MIDDLE EAST & AFRICA: OTHER NUCLEIC ACID ISOLATION AND PURIFICATION TYPES MARKET, BY REGION, 2021-2028 (USD MILLION)

9 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION

• 9.1 INTRODUCTION
  • TABLE 118 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
• 9.2 DIAGNOSTICS
  • 9.2.1 DIAGNOSTIC APPLICATIONS TO DOMINATE MARKET DURING FORECAST PERIOD
  • TABLE 119 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 120 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 121 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 122 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 123 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 124 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
• 9.3 DRUG DISCOVERY & DEVELOPMENT
  • 9.3.1 POTENTIAL OF NAIP TO HELP IN DEVELOPMENT OF DRUGS FOR RARE DISEASES TO BOOST MARKET
  • TABLE 125 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 126 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 127 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 128 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 129 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 130 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR DRUG DISCOVERY & DEVELOPMENT APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
• 9.4 PERSONALIZED MEDICINE
  • 9.4.1 RISING INCIDENCE OF CANCER AND INCREASING RESEARCH AND FUNDING TO DRIVE GROWTH
  • TABLE 131 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PERSONALIZED MEDICINE APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 132 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PERSONALIZED MEDICINE APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 133 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PERSONALIZED MEDICINE APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 134 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PERSONALIZED MEDICINE APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 135 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PERSONALIZED MEDICINE APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 136 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PERSONALIZED MEDICINE APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
• 9.5 AGRICULTURE & ANIMAL RESEARCH
  • 9.5.1 FAVORABLE FUNDING SCENARIO TO SUPPORT MARKET GROWTH
  • TABLE 137 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR AGRICULTURE & ANIMAL RESEARCH APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 138 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR AGRICULTURE & ANIMAL RESEARCH APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 139 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR AGRICULTURE & ANIMAL RESEARCH APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 140 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR AGRICULTURE & ANIMAL RESEARCH APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 141 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR AGRICULTURE & ANIMAL RESEARCH APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 142 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR AGRICULTURE & ANIMAL RESEARCH APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
• 9.6 OTHER APPLICATIONS
  • TABLE 143 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 144 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 145 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 146 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 147 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 148 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)

10 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER

• 10.1 INTRODUCTION
  • TABLE 149 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2021-2028 (USD MILLION)
• 10.2 HOSPITALS & DIAGNOSTIC CENTERS
  • 10.2.1 RISING FOCUS ON PERSONALIZED MEDICINE IN HOSPITALS TO DRIVE MARKET GROWTH
  • TABLE 150 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 151 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 152 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 153 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 154 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 155 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2021-2028 (USD MILLION)
• 10.3 ACADEMIC & GOVERNMENT RESEARCH INSTITUTES
  • 10.3.1 INCREASE IN RESEARCH INTENSITY TO DRIVE USAGE OF NUCLEIC ACID ISOLATION AND PURIFICATION SYSTEMS
  • TABLE 156 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 157 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 158 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 159 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 160 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 161 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2021-2028 (USD MILLION)
• 10.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
  • 10.4.1 INCREASING NUMBER OF RESEARCH PROJECTS IN GENOMICS AND RELATED AREAS TO DRIVE SEGMENT GROWTH
  • TABLE 162 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 163 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 164 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 165 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 166 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 167 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021-2028 (USD MILLION)
• 10.5 CONTRACT RESEARCH ORGANIZATIONS
  • 10.5.1 CONTRACT RESEARCH ORGANIZATIONS TO REGISTER STEADY GROWTH DURING FORECAST PERIOD
  • TABLE 168 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 169 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 170 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 171 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 172 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 173 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2021-2028 (USD MILLION)
• 10.6 OTHER END USERS
  • TABLE 174 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER END USERS, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 175 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 176 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 177 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 178 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 179 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET FOR OTHER END USERS, BY REGION, 2021-2028 (USD MILLION)

11 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION

• 11.1 INTRODUCTION
  • TABLE 180 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2021-2028 (USD MILLION)
• 11.2 NORTH AMERICA
  • FIGURE 32 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET SNAPSHOT
  • TABLE 181 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 182 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2021-2028 (USD MILLION)
  • TABLE 183 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 184 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 185 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 186 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 187 NORTH AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 11.2.1 US
    • 11.2.1.1 Government and private funding to support market growth
  • TABLE 188 US: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2021-2028 (USD MILLION)
  • TABLE 189 US: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 190 US: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 191 US: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 192 US: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 193 US: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 11.2.2 CANADA
    • 11.2.2.1 Growing investments in genomics to boost market demand
  • TABLE 194 CANADA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2021-2028 (USD MILLION)
  • TABLE 195 CANADA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 196 CANADA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 197 CANADA: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 198 CANADA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 199 CANADA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 11.2.3 NORTH AMERICA: RECESSION IMPACT
• 11.3 EUROPE
  • TABLE 200 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 201 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2021-2028 (USD MILLION)
  • TABLE 202 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 203 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 204 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 205 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 206 EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 11.3.1 GERMANY
    • 11.3.1.1 Germany to dominate market in Europe
  • TABLE 207 CANCER INCIDENCE IN GERMANY, BY TYPE, 2020 VS. 2027
  • TABLE 208 GERMANY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2021-2028 (USD MILLION)
  • TABLE 209 GERMANY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 210 GERMANY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 211 GERMANY: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 212 GERMANY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 213 GERMANY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 11.3.2 UK
    • 11.3.2.1 Government support for research through investments, funds, and grants to support market growth
  • TABLE 214 UK: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2021-2028 (USD MILLION)
  • TABLE 215 UK: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 216 UK: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 217 UK: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 218 UK: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 219 UK: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 11.3.3 FRANCE
    • 11.3.3.1 High cancer burden to drive market growth
  • TABLE 220 FRANCE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2021-2028 (USD MILLION)
  • TABLE 221 FRANCE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 222 FRANCE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 223 FRANCE: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 224 FRANCE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 225 FRANCE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 11.3.4 ITALY
    • 11.3.4.1 Government support to drive market growth in Italy
  • TABLE 226 ITALY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2021-2028 (USD MILLION)
  • TABLE 227 ITALY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 228 ITALY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 229 ITALY: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 230 ITALY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 231 ITALY: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 11.3.5 SPAIN
    • 11.3.5.1 High adoption of advanced diagnostic technologies to drive market growth in Spain
  • TABLE 232 SPAIN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2021-2028 (USD MILLION)
  • TABLE 233 SPAIN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 234 SPAIN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 235 SPAIN: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 236 SPAIN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 237 SPAIN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 11.3.6 REST OF EUROPE
  • TABLE 238 REST OF EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2021-2028 (USD MILLION)
  • TABLE 239 REST OF EUROPE NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 240 REST OF EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 241 REST OF EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 242 REST OF EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 243 REST OF EUROPE: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 11.3.7 EUROPE: RECESSION IMPACT
• 11.4 ASIA PACIFIC
  • FIGURE 33 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET SNAPSHOT
  • TABLE 244 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 245 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2021-2028 (USD MILLION)
  • TABLE 246 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 247 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 248 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 249 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 250 ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 11.4.1 CHINA
    • 11.4.1.1 China to register highest growth in nucleic acid isolation and purification market in Asia Pacific region
  • TABLE 251 CHINA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2021-2028 (USD MILLION)
  • TABLE 252 CHINA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 253 CHINA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 254 CHINA: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 255 CHINA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 256 CHINA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 11.4.2 JAPAN
    • 11.4.2.1 Growing number of conferences & workshops to drive market growth
  • TABLE 257 JAPAN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2021-2028 (USD MILLION)
  • TABLE 258 JAPAN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 259 JAPAN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 260 JAPAN: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 261 JAPAN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 262 JAPAN: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 11.4.3 INDIA
    • 11.4.3.1 Focused initiatives in pharmaceutical & biotechnology industries to drive market growth
  • TABLE 263 INDIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2021-2028 (USD MILLION)
  • TABLE 264 INDIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 265 INDIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 266 INDIA: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 267 INDIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 268 INDIA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 11.4.4 SOUTH KOREA
    • 11.4.4.1 Support from governments to drive market in region
  • TABLE 269 SOUTH KOREA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2021-2028 (USD MILLION)
  • TABLE 270 SOUTH KOREA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 271 SOUTH KOREA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 272 SOUTH KOREA: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 273 SOUTH KOREA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 274 SOUTH KOREA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 11.4.5 REST OF ASIA PACIFIC (ROAPAC)
  • TABLE 275 REST OF ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2021-2028 (USD MILLION)
  • TABLE 276 REST OF ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 277 REST OF ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 278 REST OF ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 279 REST OF ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 280 REST OF ASIA PACIFIC: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 11.4.6 ASIA PACIFIC: RECESSION IMPACT
• 11.5 LATIN AMERICA
  • TABLE 281 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • TABLE 282 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2021-2028 (USD MILLION)
  • TABLE 283 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 284 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 285 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 286 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 287 LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 11.5.1 BRAZIL
    • 11.5.1.1 Brazil to dominate LATAM market
  • TABLE 288 BRAZIL: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2021-2028 (USD MILLION)
  • TABLE 289 BRAZIL: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 290 BRAZIL: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 291 BRAZIL: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 292 BRAZIL: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 293 BRAZIL: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 11.5.2 MEXICO
    • 11.5.2.1 Favorable trade agreements to support imports and improve access to NAIP instruments in Mexico
  • TABLE 294 MEXICO: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2021-2028 (USD MILLION)
  • TABLE 295 MEXICO: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 296 MEXICO: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 297 MEXICO: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 298 MEXICO: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 299 MEXICO: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 11.5.3 REST OF LATIN AMERICA
  • TABLE 300 REST OF LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2021-2028 (USD MILLION)
  • TABLE 301 REST OF LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 302 REST OF LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 303 REST OF LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 304 REST OF LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 305 REST OF LATIN AMERICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 11.5.4 LATIN AMERICA: RECESSION IMPACT
• 11.6 MIDDLE EAST & AFRICA
  • TABLE 306 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY REGION, 2021-2028 (USD MILLION)
  • TABLE 307 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2021-2028 (USD MILLION)
  • TABLE 308 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 309 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 310 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 311 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 312 MIDDLE EAST & AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 11.6.1 MIDDLE EAST
    • 11.6.1.1 Growing focus on molecular diagnostics and research to drive market
  • TABLE 313 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2021-2028 (USD MILLION)
  • TABLE 314 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 315 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 316 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 317 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 318 MIDDLE EAST: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 11.6.2 AFRICA
    • 11.6.2.1 Government support for research studies to fuel growth
  • TABLE 319 AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY METHOD, 2021-2028 (USD MILLION)
  • TABLE 320 AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 321 AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
  • TABLE 322 AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION INSTRUMENTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • TABLE 323 AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • TABLE 324 AFRICA: NUCLEIC ACID ISOLATION AND PURIFICATION MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 11.6.3 MIDDLE EAST & AFRICA: RECESSION IMPACT

12 COMPETITIVE LANDSCAPE

• 12.1 INTRODUCTION
• 12.2 RIGHT-TO-WIN APPROACHES ADOPTED BY KEY PLAYERS
  • TABLE 325 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: STRATEGIES ADOPTED
• 12.3 REVENUE ANALYSIS
  • FIGURE 34 REVENUE ANALYSIS OF KEY PLAYERS (2018-2022)
• 12.4 MARKET SHARE ANALYSIS
  • FIGURE 35 MARKET SHARE ANALYSIS OF KEY PLAYERS (2022)
  • TABLE 326 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: DEGREE OF COMPETITION
• 12.5 COMPANY EVALUATION MATRIX
  • 12.5.1 STARS
  • 12.5.2 EMERGING LEADERS
  • 12.5.3 PERVASIVE PLAYERS
  • 12.5.4 PARTICIPANTS
  • FIGURE 36 COMPANY EVALUATION MATRIX, 2022
  • 12.5.5 COMPANY FOOTPRINT ANALYSIS
    • 12.5.5.1 Company footprint
  • TABLE 327 COMPANY FOOTPRINT ANALYSIS: KEY PLAYERS
    • 12.5.5.2 Company product footprint
  • TABLE 328 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: PRODUCT FOOTPRINT ANALYSIS OF KEY PLAYERS
    • 12.5.5.3 Company regional footprint
  • TABLE 329 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS
• 12.6 START-UP/SME EVALUATION MATRIX
  • 12.6.1 PROGRESSIVE COMPANIES
  • 12.6.2 RESPONSIVE COMPANIES
  • 12.6.3 DYNAMIC COMPANIES
  • 12.6.4 STARTING BLOCKS
  • FIGURE 37 START-UP/SME EVALUATION MATRIX, 2022
  • 12.6.5 COMPETITIVE BENCHMARKING
  • TABLE 330 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: DETAILED LIST OF KEY START-UP/SME PLAYERS
  • TABLE 331 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: COMPETITIVE BENCHMARKING OF START-UP/SME PLAYERS
• 12.7 COMPETITIVE SCENARIO AND TRENDS
  • 12.7.1 PRODUCT LAUNCHES
  • TABLE 332 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: PRODUCT LAUNCHES, JANUARY 2020-OCTOBER 2023
  • 12.7.2 DEALS
  • TABLE 333 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: DEALS, JANUARY 2020 TO OCTOBER 2023
  • 12.7.3 OTHER DEVELOPMENTS
  • TABLE 334 NUCLEIC ACID ISOLATION AND PURIFICATION MARKET: OTHER DEVELOPMENTS, JANUARY 2020 TO OCTOBER 2023

13 COMPANY PROFILES

• (Business Overview, Products Offered, Recent Developments, MnM View Right to win, Strategic choices made, Weaknesses and competitive threats) **
• 13.1 MAJOR PLAYERS
  • 13.1.1 THERMO FISHER SCIENTIFIC INC.
  • TABLE 335 THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW
  • FIGURE 38 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2022)
  • 13.1.2 QIAGEN
  • TABLE 336 QIAGEN: BUSINESS OVERVIEW
  • FIGURE 39 QIAGEN: COMPANY SNAPSHOT (2022)
  • 13.1.3 F. HOFFMANN-LA ROCHE LTD.
  • TABLE 337 F. HOFFMANN-LA ROCHE LTD.: BUSINESS OVERVIEW
  • FIGURE 40 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2022)
  • 13.1.4 MERCK KGAA
  • TABLE 338 MERCK KGAA: BUSINESS OVERVIEW
  • FIGURE 41 MERCK KGAA: COMPANY SNAPSHOT (2022)
  • 13.1.5 PROMEGA CORPORATION
  • TABLE 339 PROMEGA CORPORATION: BUSINESS OVERVIEW
  • 13.1.6 AGILENT TECHNOLOGIES, INC.
  • TABLE 340 AGILENT TECHNOLOGIES, INC.: BUSINESS OVERVIEW
  • FIGURE 42 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2022)
  • 13.1.7 DANAHER
  • TABLE 341 DANAHER: BUSINESS OVERVIEW
  • FIGURE 43 DANAHER: COMPANY SNAPSHOT (2022)
  • 13.1.8 BIO-RAD LABORATORIES, INC.
  • TABLE 342 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW
  • FIGURE 44 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2022)
  • 13.1.9 ILLUMINA, INC.
  • TABLE 343 ILLUMINA, INC.: BUSINESS OVERVIEW
  • FIGURE 45 ILLUMINA, INC.: COMPANY SNAPSHOT (2022)
  • 13.1.10 TAKARA BIO INC.
  • TABLE 344 TAKARA BIO INC.: BUSINESS OVERVIEW
  • FIGURE 46 TAKARA BIO INC.: COMPANY SNAPSHOT (2022)
  • 13.1.11 NEW ENGLAND BIOLABS
  • TABLE 345 NEW ENGLAND BIOLABS: BUSINESS OVERVIEW
  • 13.1.12 ABCAM PLC
  • TABLE 346 ABCAM PLC: BUSINESS OVERVIEW
  • FIGURE 47 ABCAM PLC: COMPANY SNAPSHOT (2022)
• 13.2 OTHER COMPANIES
  • 13.2.1 KILPEST INDIA LIMITED
  • TABLE 347 KILPEST INDIA LIMITED: COMPANY OVERVIEW
  • 13.2.2 APICAL SCIENTIFIC SDN. BHD.
  • TABLE 348 APICAL SCIENTIFIC SDN. BHD.: COMPANY OVERVIEW
  • 13.2.3 ENDRESS+HAUSER GROUP SERVICES AG
  • TABLE 349 ENDRESS+HAUSER GROUP SERVICES AG: COMPANY OVERVIEW
  • 13.2.4 GENAXXON BIOSCIENCE GMBH
  • TABLE 350 GENAXXON BIOSCIENCE GMBH: COMPANY OVERVIEW
  • 13.2.5 LGC BIOSEARCH TECHNOLOGIES
  • TABLE 351 LGC BIOSEARCH TECHNOLOGIES: COMPANY OVERVIEW
  • 13.2.6 ZYMO RESEARCH CORPORATION
  • TABLE 352 ZYMO RESEARCH CORPORATION: COMPANY OVERVIEW
  • 13.2.7 NORGEN BIOTEK CORP.
  • TABLE 353 NORGEN BIOTEK CORP.: COMPANY OVERVIEW
  • 13.2.8 OMEGA BIO-TEK, INC.
  • TABLE 354 OMEGA BIO-TEK, INC.: COMPANY OVERVIEW
  • 13.2.9 FAVORGEN BIOTECH CORPORATION
  • TABLE 355 FAVORGEN BIOTECH CORPORATION: COMPANY OVERVIEW
  • 13.2.10 TIANGEN BIOTECH(BEIJING)CO., LTD.
  • TABLE 356 TIANGEN BIOTECH(BEIJING)CO., LTD.: COMPANY OVERVIEW
  • 13.2.11 AUTOGEN INC.
  • TABLE 357 AUTOGEN INC.: COMPANY OVERVIEW
  • 13.2.12 PCR BIOSYSTEMS
  • TABLE 358 PCR BIOSYSTEMS: COMPANY OVERVIEW
  • 13.2.13 BIOGENUIX
  • TABLE 359 BIOGENUIX: COMPANY OVERVIEW
• *Details on Business Overview, Products Offered, Recent Developments, MnM View, Right to win, Strategic choices made, Weaknesses and competitive threats might not be captured in case of unlisted companies.

14 APPENDIX

• 14.1 DISCUSSION GUIDE
• 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 14.3 CUSTOMIZATION OPTIONS
• 14.4 RELATED REPORTS
• 14.5 AUTHOR DETAILS